How Treatment Works

Treatment That Addresses the Cause, Not Just the Lesion

Most HS treatments are designed to manage what is visible — the abscess, the discharge, the flare. At EPOH, treatment begins one layer deeper: at the internal imbalance that makes the skin behave the way it does.

See How It Works View the Full Protocol

"The goal is not just to control symptoms, but to understand why the condition is occurring in the first place."

— Dr. Adil Moulanchikkal, BAMS · EPOH

300 HS cases in remission with the EPOH HS Protocol

Treatment at a Glance

Phase-based & sequential

Each phase builds on the previous. Sequence matters.

Personalised to your pattern

No two HS cases are identical. Treatment follows your drivers.

Internal correction first

Gut, hormones, immunity — addressed before the skin.

Built for sustained remission

Not a temporary fix. The aim is a stable, non-recurring state.

A personalised evaluation is required before treatment begins. This ensures the protocol addresses your specific pattern.

Start a Conversation
Why Recurrence Happens

Most Treatments Address the Symptom. The Cause Remains.

Understanding why previous treatments have not provided lasting relief is not a criticism of care received — it reflects a genuine structural limitation in how HS has traditionally been approached. Each treatment layer has a role, but none reaches the root of recurrence.

Approach 01

Antibiotics

Antibiotics reduce bacterial load and dampen inflammation temporarily. They are a useful acute tool. Over time, however, repeated courses disrupt gut microbiome balance — which is itself a key driver of HS in many patients. The internal environment is not improved; it is often worsened.

Result: Temporary reduction, followed by recurrence often at greater intensity.

Approach 02

Steroids & Biologics

These agents suppress immune signalling — reducing inflammatory activity in the short term. They do not correct why the immune system is misfiring. The underlying triggers (gut imbalance, hormonal dysregulation, metabolic dysfunction) remain active. When suppression is withdrawn, the condition reasserts itself.

Result: Control maintained only while suppression continues. Root cause untouched.

Approach 03

Surgery

Surgical excision removes existing lesions, tunnels, and scar tissue. It is sometimes appropriate in advanced structural cases. What it cannot do is alter the systemic environment that produced those lesions. Without internal correction, the same processes that caused the first set of lesions continue.

Result: New lesions form — often in adjacent areas. Recurrence rates after surgery remain high.

"If your HS keeps coming back despite treatment, it usually means the root cause has not been addressed — not that the condition is untreatable."

The Treatment Architecture

Five Phases. One Direction: Internal Correction.

The EPOH HS Protocol™ is structured as five sequential phases. Each phase has a specific biological role. The sequence is intentional — attempting to reach later phases without completing earlier ones produces incomplete results.

The LIFES Framework

Note

The pace of each phase is determined by clinical response, not a fixed calendar. Progression is guided by internal markers, not time alone.

L
Phase 01 · Lowering the Load

Reducing Inflammatory Burden

Before healing can begin, the system must be de-loaded

Chronic HS patients carry a sustained inflammatory load — accumulated over years of unresolved internal triggers. This inflammation does not reset between flares; it compounds. Phase L addresses this accumulation directly, lowering the baseline inflammatory state so that subsequent healing phases can function.

From an Ayurvedic perspective, this corresponds to the reduction of Ama — the accumulated toxic metabolic load — that sustains the inflammatory cycle. Without clearing this load, deeper correction remains inaccessible.

  • Reducing dietary and metabolic inputs that sustain chronic inflammation
  • Supporting the digestive system's ability to process and eliminate efficiently
  • Calming immune overactivation through internal formulations
  • Establishing the baseline stability required for deeper phases

Typical Duration

4–8 weeks, varying by disease duration and baseline inflammatory state

I
Phase 02 · Internal Healing

Gut Restoration & Immune Recalibration

Correcting the internal environment that sustains HS

In the majority of HS patients, gut dysfunction is not a secondary consideration — it is a primary driver. When the gut barrier is compromised, inflammatory signals leak into circulation continuously, keeping the immune system in a state of chronic activation. Skin lesions are, in part, this activation expressing at the tissue level.

Phase I focuses on restoring gut integrity and rebalancing immune signalling. This phase also addresses hormonal imbalances where present — particularly in women with PCOS-linked or cyclical HS — since hormonal patterns directly influence flare frequency and intensity.

  • Gut lining restoration and microbiome support
  • Reducing immune hyperactivation at its source
  • Hormonal regulation where androgen dominance or insulin resistance is present
  • Metabolic correction for patients with obesity-linked HS

Typical Duration

8–16 weeks; longer in cases with complex hormonal or metabolic involvement

F
Phase 03 · Functional Detox

Deep Tissue Cleansing & Channel Clearance

Clearing accumulated dysfunction from deeper tissue layers

Long-standing HS involves not only surface lesions but deeper tissue involvement — compromised lymphatic flow, fibrotic change, and accumulated inflammatory residue in subcutaneous layers. Phase F addresses this structural layer through formulations and supportive interventions that clear accumulated toxin load from deeper channels.

This phase targets what persists even after systemic inflammation has lowered — the residual tissue dysfunction that predisposes areas to repeated lesion formation. In Ayurvedic terms, this is Srotorodha: blockage of internal channels that prevents the body from self-clearing effectively.

  • Lymphatic support and drainage improvement in affected areas
  • Tissue-level cleansing formulations tailored to lesion sites
  • Addressing fibrotic and scar tissue where healing is impeded
  • Clearing the residual load from historically active areas

Typical Duration

6–12 weeks; concurrent with Phase I in many patients

E
Phase 04 · External Care

Tissue Repair & Surface Healing

Supporting recovery of damaged skin and sinus tracts

With internal correction underway, Phase E focuses on the skin itself — accelerating repair of active lesions, supporting healing of sinus tracts, reducing scarring, and restoring tissue integrity in affected areas. This phase works because internal conditions have shifted; external care applied without internal correction produces limited and temporary results.

External formulations are personalised to lesion type, location, and stage. Management of friction, heat, and moisture in affected areas is also structured during this phase.

  • Topical formulations for active lesion resolution and post-lesion healing
  • Sinus tract healing support where tunnelling is present
  • Scar tissue management and skin integrity restoration
  • Practical guidance on triggering factors specific to lesion location

Typical Duration

Ongoing through Phase I–F; intensified as internal correction takes effect

S
Phase 05 · Sustaining Remission

Long-Term Stability & Recurrence Prevention

Building internal resilience so HS does not return

Remission is not the absence of active lesions — it is the stable internal state that makes recurrence unlikely. Phase S is the longest phase and, in many ways, the most important: it is where the gains made in Phases L through E are consolidated and made durable.

This phase includes ongoing monitoring, lifestyle integration, formulation tapering, and strengthening of immune resilience. Many patients reach Phase S and find that, for the first time in years, they are not planning around their next flare.

  • Maintenance formulations that support systemic stability
  • Lifestyle and dietary patterns that prevent trigger reactivation
  • Ongoing monitoring and adjustment as seasons, hormones, and stress patterns shift
  • Resilience-building to reduce vulnerability to occasional triggers

Duration

Ongoing maintenance; active monitoring for 6–12 months post-stabilisation

Control vs correction — why suppression-based treatment differs from root-cause resolution

Control vs correction — why suppression-based treatment differs from root-cause resolution

Personalised Formulations

Not a Protocol. A Pattern-Matched Treatment.

Each formulation is built from Ayurvedic classical medicine — adapted to the patient's specific doshic pattern, disease stage, and gut status. No two formulations are identical because no two presentations of HS are identical.

Personalised Ayurvedic Formulation System — EPOH

Every patient at EPOH receives formulations developed specifically for their pattern of HS — their disease stage, dominant triggers, hormonal profile, and gut status. There are no standard combinations. The formulation system works in five functional categories:

🌱

Detox & Blood Purification

AyurvedaRakta Shodhana · Ama Clearance

Reduces accumulated inflammatory load and supports the body's ability to clear toxins from circulation. Addresses blood-level imbalance that sustains skin lesion formation.

🌿

Skin Healing & Tissue Repair

AyurvedaDhatu Repair · Vrana Ropana

Promotes healing of active nodules, draining lesions, and sinus tracts. Supports collagen and tissue integrity in historically affected areas. Both oral and topical formulations where appropriate.

⚖️

Hormonal Balance Support

AyurvedaPitta-Meda Correction · Endocrine Balance

Targets androgen excess, PCOS-related patterns, and insulin resistance where these are identified as drivers. Particularly important in women with cyclical flare patterns.

🔄

Gut Restoration Formula

AyurvedaAgni Restoration · Srotas Repair

Restores digestive function and gut barrier integrity. Addresses the microbiome disruption often caused by repeated antibiotic courses. Reduces the internal toxin production that sustains chronic inflammation.

🛡️

Recurrence Prevention Rasayana

Strengthens long-term immune resilience and systemic stability. Used in Phase S to maintain the internal environment achieved through earlier phases. Prevention, not maintenance suppression.

🧬

Personalisation Principle

Formulations are compounded based on your clinical assessment — not selected from a menu. The ratio, combination, and administration method of each formulation is determined by your specific imbalance pattern, disease stage, and response at each phase.

Realistic Expectations

What the Healing Process Actually Looks Like

Honesty about timelines is not a weakness — it is a clinical requirement. HS that has been active for years does not resolve in weeks. Here is what the corrective process typically looks like.

Weeks 1–4

Internal Stabilisation

The initial period focuses on reducing inflammatory load and beginning gut correction. New flares may still occur during this phase. This is expected — the system is clearing, not worsening. Most patients notice subtle shifts: slightly less intensity per flare, somewhat longer gaps between them.

Months 2–4

Reduction in Frequency & Intensity

As internal correction progresses, the pattern typically shifts: flares become less frequent, shorter in duration, and less severe. Active lesions begin to resolve more completely between cycles. This period is where most patients first feel that something is genuinely different from prior treatments.

Months 4–8

Sustained Reduction & Tissue Healing

With internal imbalance progressively corrected, longer flare-free periods emerge. Tissue healing in previously affected areas becomes more visible. Hormonal patterns stabilise for women with cyclical HS. The goal shifts from managing flares to maintaining a stable internal state.

Months 8+

Remission & Prevention Phase

Stable remission — defined not as perfect skin but as a non-recurring, manageable baseline — becomes the focus. Treatment continues at a maintenance level, building resilience and monitoring for trigger reactivation. Results at this stage vary by disease duration, but the aim is a life not structured around the next flare.

An Honest Note

Not every patient responds equally. Disease duration, degree of organ involvement, and remaining biological repair capacity all influence outcomes. Some patients — particularly those with very advanced fibrotic HS or irreversible organ damage — may not achieve full remission.

A personalised evaluation is the only way to assess your specific response potential. We do not over-promise. We explain clearly what correction looks like for your pattern.

What Makes Cases Respond

  • ✓

    Remaining gut repair capacity

  • ✓

    Hormonal patterns that can be rebalanced

  • ✓

    Disease duration under 10 years (though longer cases do respond)

  • ✓

    Commitment to the full protocol duration

Approach Comparison

The Difference Is in What Is Being Addressed

Aspect Conventional Approach EPOH Approach
Primary target Surface lesion, bacterial load, inflammatory signalling Internal imbalance driving lesion formation — gut, hormones, immunity
Treatment model Management — keep symptoms under control Correction — address and resolve underlying drivers
Personalisation Protocol-based (same antibiotic course for most patients) Pattern-matched to individual driver profile
Recurrence logic Managed as expected feature of the disease Recurrence indicates unresolved root cause — addressed directly
Gut health Not typically addressed (antibiotics often worsen it) Central treatment priority; gut is often the primary driver
Hormonal factors Addressed separately, if at all (hormonal pills) Integrated into treatment — especially for women with PCOS-linked HS
Long-term aim Minimise flare frequency; maintain control Stable internal state where flares no longer occur
Begin Your Evaluation

Before Treatment, There Must Be Understanding

Every patient who begins treatment at EPOH first goes through a structured clinical evaluation. This is not a formality — it determines which phases are most urgent, which formulations are most appropriate, and whether this approach is the right fit.

The intake form to the right begins that conversation. Share the details of your case — disease duration, what you have tried, your primary concern — and the clinic will follow up to discuss your specific pattern.

01

Submit the form with your case details

02

The clinic reviews and assesses your suitability

03

A detailed clinical conversation follows — not a sales call

Prefer to speak directly? WhatsApp the clinic at +91 88847 22246 or call +91 88847 22246.

Clinical Intake

Evaluate Your Case

Responses within 1 working day · No unsolicited follow-up

Received

Your intake has been submitted

The clinic will review your case and be in touch within one working day to discuss the next step.

Go Deeper

Related Clinical Reading

All Articles